BioAlliance Pharma Receives Approval to Begin ReLive Phase III Clinical Trial in Primary Liver Cancer in the US and Germany

BioAlliance Pharma SA (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology and to… Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an